Fidelity Advisor Biotechnology Fund - Class I (FBTIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
27.97
+0.71 (2.60%)
May 30, 2025, 8:09 AM EDT
FBTIX Holdings List
As of Mar 31, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ABBV | AbbVie Inc. | 23.23% |
2 | AMGN | Amgen Inc. | 7.83% |
3 | GILD | Gilead Sciences, Inc. | 7.47% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.34% |
5 | ALNY | Alnylam Pharmaceuticals, Inc. | 6.12% |
6 | ASND | Ascendis Pharma A/S | 4.87% |
7 | ARGX | argenx SE | 4.17% |
8 | NUVL | Nuvalent, Inc. | 2.08% |
9 | XENE | Xenon Pharmaceuticals Inc. | 1.71% |
10 | VRDN | Viridian Therapeutics, Inc. | 1.65% |
11 | SRRK | Scholar Rock Holding Corporation | 1.33% |
12 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.31% |
13 | APGE | Apogee Therapeutics, Inc. | 1.26% |
14 | CYTK | Cytokinetics, Incorporated | 1.16% |
15 | SLNO | Soleno Therapeutics, Inc. | 1.09% |
16 | MRUS | Merus N.V. | 1.06% |
17 | VKTX | Viking Therapeutics, Inc. | 1.05% |
18 | EXAS | Exact Sciences Corporation | 1.04% |
19 | PCVX | Vaxcyte, Inc. | 1.03% |
20 | SRPT | Sarepta Therapeutics, Inc. | 0.88% |
21 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.81% |
22 | ACLX | Arcellx, Inc. | 0.76% |
23 | SYRE | Spyre Therapeutics, Inc. | 0.76% |
24 | n/a | Bridgebio Pharma Inc Pipe | 0.76% |
25 | ELVN | Enliven Therapeutics, Inc. | 0.71% |
26 | JANX | Janux Therapeutics, Inc. | 0.62% |
27 | AKRO | Akero Therapeutics, Inc. | 0.62% |
28 | CLDX | Celldex Therapeutics, Inc. | 0.61% |
29 | IRON | Disc Medicine, Inc. | 0.59% |
30 | DNTH | Dianthus Therapeutics, Inc. | 0.58% |
31 | COGT | Cogent Biosciences, Inc. | 0.57% |
32 | TVTX | Travere Therapeutics, Inc. | 0.56% |
33 | NRIX | Nurix Therapeutics, Inc. | 0.56% |
34 | SMMT | Summit Therapeutics Inc. | 0.54% |
35 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.54% |
36 | ZBIO | Zenas BioPharma, Inc. | 0.53% |
37 | ORKA | Oruka Therapeutics, Inc. | 0.48% |
38 | EBR: UCB | UCB SA | 0.47% |
39 | DAWN | Day One Biopharmaceuticals, Inc. | 0.45% |
40 | GPCR | Structure Therapeutics Inc. | 0.45% |
41 | BCAX | Bicara Therapeutics Inc. | 0.45% |
42 | KYMR | Kymera Therapeutics, Inc. | 0.44% |
43 | NAMS | NewAmsterdam Pharma Company N.V. | 0.42% |
44 | IMVT | Immunovant, Inc. | 0.40% |
45 | DNLI | Denali Therapeutics Inc. | 0.39% |
46 | n/a | Sonoma Biotherap Ser B Pfd Pp | 0.39% |
47 | CGON | CG Oncology, Inc. | 0.39% |
48 | MLTX | MoonLake Immunotherapeutics | 0.37% |
49 | n/a | Crescent Biopharma Inc Pipe | 0.36% |
50 | LEGN | Legend Biotech Corporation | 0.35% |
51 | MLYS | Mineralys Therapeutics, Inc. | 0.34% |
52 | RZLT | Rezolute, Inc. | 0.34% |
53 | n/a | Immunovant Inc Pipe | 0.33% |
54 | n/a | Fidelity Cash Central Fund | 0.33% |
55 | VIR | Vir Biotechnology, Inc. | 0.29% |
56 | TECX | Tectonic Therapeutic, Inc. | 0.27% |
57 | VERA | Vera Therapeutics, Inc. | 0.26% |
58 | UPB | Upstream Bio, Inc. | 0.26% |
59 | CATX | Perspective Therapeutics, Inc. | 0.25% |
60 | IDYA | IDEAYA Biosciences, Inc. | 0.24% |
61 | n/a | Sonoma Biotherap Ser B1 Pfd Pp | 0.24% |
62 | ZLAB | Zai Lab Limited | 0.23% |
63 | n/a | Bright Peak Thera Ser B Pc Pp | 0.22% |
64 | n/a | Kartos Therapeutic Ser C Pc Pp | 0.22% |
65 | TRML | Tourmaline Bio, Inc. | 0.21% |
66 | n/a | Endeavor Biomedici Ser C Pc Pp | 0.20% |
67 | ATXS | Astria Therapeutics, Inc. | 0.18% |
68 | DYN | Dyne Therapeutics, Inc. | 0.17% |
69 | n/a | Lifemine Therapeutics Ser C Pp | 0.17% |
70 | n/a | Wugen Inc Ser B Pc Pp | 0.16% |
71 | TYRA | Tyra Biosciences, Inc. | 0.13% |
72 | WVE | Wave Life Sciences Ltd. | 0.13% |
73 | RAPP | Rapport Therapeutics, Inc. | 0.13% |
74 | n/a | T-Knife Therapeutics B Pc Pp | 0.13% |
75 | MREO | Mereo BioPharma Group plc | 0.12% |
76 | n/a | Candid Therapeutic Ser B Pc Pp | 0.12% |
77 | CRGX | CARGO Therapeutics, Inc. | 0.11% |
78 | GLUE | Monte Rosa Therapeutics, Inc. | 0.11% |
79 | n/a | Cardurion Pharmace Ser B Pc Pp | 0.11% |
80 | n/a | Parabilis Medicines Inc Ser D | 0.10% |
81 | n/a | Enliven Therapeutics Pipe | 0.10% |
82 | AUTL | Autolus Therapeutics plc | 0.07% |
83 | n/a | Bright Peak Therapeutics Ser C | 0.07% |
84 | STOK | Stoke Therapeutics, Inc. | 0.07% |
85 | n/a | Wugen Inc Conv 10% 06/14/25 Pp | 0.06% |
86 | MAZE | Maze Therapeutics, Inc. | 0.05% |
87 | n/a | Jade Biosciences Inc Pipe | 0.05% |
88 | n/a | Tectonic Therapeutic Inc Pipe | 0.04% |
89 | n/a | Warrant on Astria Therapeutics Inc | 0.03% |
90 | VRTX | Vertex Pharmaceuticals Incorporated | 0.02% |
91 | n/a | Treeline Biosci Ser A Pc Pp | 0.02% |
92 | n/a | Scholar Rock Wt 12/31/25 Pp | 0.01% |
93 | BBIO | BridgeBio Pharma, Inc. | 0.00% |
94 | n/a | Warrant on Enliven Therapeutics Inc | 0.00% |
95 | n/a | Afferent Pharma Ser C Pc Pp | 0.00% |
96 | n/a | Cash | -0.36% |
As of Mar 31, 2025